Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fogari

Showing results (151-160 of 171) with videos related to

Pageof 18
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1992
Nitrendipine 20 mg once daily versus nicardipine slow release 40 mg twice daily in mild essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoringR Fogari, F Tettamanti, A Zoppi, et al.
Journal of Hypertension|September 21, 2001
A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertensionP Palatini, E Malacco, R Fogari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 26, 2011
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trialR Fogari, A Mugellini, M Destro, et al.
Journal of Human Hypertension|January 12, 2007
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patientsR Fogari, A Zoppi, G Derosa, et al.
Journal of Human Hypertension|January 7, 1998
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetesR Fogari, A Zoppi, P Lazzari, et al.
Acta Cardiologica|January 1, 1972
[Kinetocardiography of the obstructive chronic bronchopneumopathies]G Finardi, M Morpurgo, A Venco, et al.
La Clinica Terapeutica|September 1, 1993
[Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension]L Poletti, R Fogari, M A Bressan, et al.
Cardiovascular Drugs and Therapy|June 1, 1992
Comparison of bisoprolol and diazepam in the treatment of cardiac neurosisR Fogari, A Zoppi, L Corradi, et al.
Journal of Hypertension|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalaprilN J Holwerda, R Fogari, P Angeli, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipineL Corea, O Cardoni, R Fogari, et al.
Pageof 18

Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1992
Nitrendipine 20 mg once daily versus nicardipine slow release 40 mg twice daily in mild essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoringR Fogari, F Tettamanti, A Zoppi, et al.
Journal of Hypertension|September 21, 2001
A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertensionP Palatini, E Malacco, R Fogari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 26, 2011
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trialR Fogari, A Mugellini, M Destro, et al.
Journal of Human Hypertension|January 12, 2007
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patientsR Fogari, A Zoppi, G Derosa, et al.
Journal of Human Hypertension|January 7, 1998
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetesR Fogari, A Zoppi, P Lazzari, et al.
Acta Cardiologica|January 1, 1972
[Kinetocardiography of the obstructive chronic bronchopneumopathies]G Finardi, M Morpurgo, A Venco, et al.
La Clinica Terapeutica|September 1, 1993
[Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension]L Poletti, R Fogari, M A Bressan, et al.
Cardiovascular Drugs and Therapy|June 1, 1992
Comparison of bisoprolol and diazepam in the treatment of cardiac neurosisR Fogari, A Zoppi, L Corradi, et al.
Journal of Hypertension|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalaprilN J Holwerda, R Fogari, P Angeli, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipineL Corea, O Cardoni, R Fogari, et al.
Pageof 18